CellCure Neurosciences Ltd.
Cell Cure Neurosciences is a biotechnology company owned by BioTime, Teva Pharmaceutical Industries and Hadasit Bio-Holdings is focused on developing cell based therapies for retinal and neural degenerative disease. Our first developed product, OpRegen®, is aimed to treat Age-Related Macular Degeneration, based on human embryonic stem cells (hESC), which, for the first time in the history of medicine, open the door to industrial-scale manufacture of any cell type in the human body.